Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: Influence of long-term melatonin treatment

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chuffa, Luiz Gustavo A ^a   Fioruci Fontanelli, Beatriz A ^a,b   Mendes, Leonardo O ^a,b   Fávaro, Wagner J ^b   Pinheiro, Patricia Fernanda F ^a   Martinez, Marcelo ^c   Martinez, Francisco Eduardo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALCOHOL; MELATONIN; PLACEBO; SESAME SEED OIL;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ESTRUS CYCLE; EVENING DOSAGE; FEMALE; HISTOPATHOLOGY; HUMAN; NONHUMAN; NUTRITIONAL ASSESSMENT; OVARY CARCINOMA; PATHOLOGICAL ANATOMY; RAT; RAT MODEL; RISK REDUCTION; TUMOR REGRESSION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA; ESTROUS CYCLE; ETHANOL; FEMALE; MELATONIN; OVARIAN NEOPLASMS; RATS;

EID: 84893171982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081676     Document Type: Article

References (53)

1. Stakleff KD, Von Gruenigen VE (2003) Rodent models for ovarian cancer research. Int J Gynecol Cancer 13: 405-412. (Pubitemid 38220657)
2. Vanderhyden BC (2005) Loss of ovarian function and the risk of ovarian cancer. Cell Tiss Res 322: 117-124.
3. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, et al. (2007) Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem 102: 1117-1129. (Pubitemid 350220033)
4. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, et al. (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5: 35-44. (Pubitemid 350218778)
5. Fleming JS, Beaugié CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247: 4-21. (Pubitemid 43277703)
6. Fathalla MF (1971) Incessant ovulation - a factor in ovarian neoplasia? Lancet 2: 163.
7. Konishi I, Kuroda H, Mandai M (1999) Review: gonadotropins and development of ovarian cancer. Oncology 57: 45-48. (Pubitemid 29494884)
8. Murdoch WJ (2008) Ovulatory factor in ovarian carcinogenesis. Adv Exp Med Biol 622: 119-128.
9. Ozols RF, Rubin SC, Thomas GM, Robboy SJ (2005) Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME, editors. Principles and Practice of Gynecologic Oncology, fifth ed. Lippincott Williams & Wilkins, Philadelphia, PA, 903-904.
10. Lynch HT, Caseyb MJ, Snydera CL, Bewtrac C, Lyncha JF, et al. (2009) Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management. Mol Oncol 3: 97-137.
11. Nishida T, Sugiyama T, Kataoka A, Ushijima K, Yakushiji M (1998) Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of a 7,12-dimethylbenz[alpha]anthracene-coated suture: common epithelial tumors of the ovary in rats? Cancer 83: 965-970. (Pubitemid 28401931)
12. Nishida T, Oda T, Sugiyama T, Nishida T, Nishimura H, et al. (1982) Squamous cell carcinoma arising from an epidermoid cyst in the ovary of rat treated with 7,12-dimethylbenz[a]anthracene. Gann 73: 153-157. (Pubitemid 12100997)
13. Nishida T, Sugiyama T, Katabuchi H, Kamura N, Yakushiji M, et al. (1986) Histologic origin of rat ovarian adenocarcinoma induced by direct application of 7,12dimethylbenz[a]anthracene. Acta Obstet Gynecol Jpn 38: 570-574. (Pubitemid 16112973)
14. Mello NK, Bree MP, Mendelson JH, Ellingboe J, King NW, et al. (1983) Alcohol self-administration disrupts reproductive function in 24 female macaque monkeys. Science 221: 677-679. (Pubitemid 13026090)
15. La Vecchia C, Negri E, Franceschi S, Parazzini F, Gentile A, et al. (1992) Alcohol and epithelial ovarian cancer. J Clin Epidemiol 45: 1025-1030.
16. Rota M, Pasquali E, Scotti L, Pelucchi C, Tramacere I, et al. (2012) Alcohol drinking and epithelial ovarian cancer risk: a systematic review and meta-analysis. Gynecol Oncol 125: 758-763.
17. Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE (2008) Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 112: 1169-1177. (Pubitemid 351304604)
18. Mardones J, Segovia-Riquelme N (1983) Thirty-two years of selection of rats by ethanol preference: UChA and UChB strains. Neurobehav Toxicol Teratol 5: 171-178. (Pubitemid 13086831)
19. Masana MI, Dubocovich ML (2001) Melatonin receptor signaling: finding the path through the dark. Sci STKE 107: pe39.
20. Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE (1992) The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 64: 249-256.
21. Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, et al. (2008) Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Targets 8: 691-702.
22. Reiter RJ (2004) Mechanisms of cancer inhibition by melatonin. J Pineal Res 3: 213-214.
23. Conti A, Maestroni GJM (1995) The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 19: 103-110.
24. Chada S, Ramesh R, Mhashilkar AM (2003) Cytokine- and chemokine-based gene therapy for cancer. Curr Opin Mol Ther 5: 463-474. (Pubitemid 37304711)
25. Sauer LA, Dauchy RT, Blask DE (2001) Polyunsaturated fatty acids, melatonin and cancer progression. Biochem Pharmacol 61: 1455-1462. (Pubitemid 32476900)
26. Hoyer PB, Davis JR, Bedrnicek JB, Marion SL, Christian PJ (2009) Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure. Gynecol Oncol 112: 610-615.
27. Chuffa LG, Amorim JP, Teixeira GR, Mendes LO, Fioruci BA, et al. (2011a) Long-term exogenous melatonin treatment modulates overall feed efficiency and protects ovarian tissue against injuries caused by ethanol-induced oxidative stress in adult UChB rats. Alcohol Clin Exp Res 35: 1498-1508.
28. Chuffa LG, Seiva FR, Favaro WJ, Teixeira GR, Amorim JP, et al. (2011b) Melatonin reduces LH, 17 beta-estradiol and induces differential regulation of sex steroid receptors in reproductive tissues during rat ovulation. Reprod Biol Endocrinol 9: 108.
29. Berstad P, Ma H, Bernstein L, Ursin G (2008) Alcohol intake and breast cancer risk among young women. Breast Cancer Res Treat 108: 113-120. (Pubitemid 351623238)
30. Jacinto-Alemán LF, García-Carrancá A, Leyba-Huerta ER, Zenteno-Galindo E, Jiménez-Farfán MD, et al. (2013) erbB expression changes in ethanol and 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis. Med Oral Patol Oral Cir Bucal 18: e325-e331.
31. Seitz HK, Wang XD (2013) The role of cytochrome P450 2E1 in ethanol-mediated carcinogenesis. Subcell Biochem 67: 131-143.
32. Schouten LJ, Zeegers MP, Goldbohm RA, Van Den Brandt PA (2004) Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 15: 201-209. (Pubitemid 38445367)
33. Chuffa LG, Padovani CR, Martinez FE (2009) Ovarian structure and hormonal status of the UChA and UChB adult rats in response to ethanol. Maturitas 62: 21-29.
34. Chuffa LG, Seiva FR, Fávaro WJ, Amorim JP, Teixeira GR, et al. (2013) Melatonin and ethanol intake exert opposite effects on circulating estradiol and progesterone and differentially regulate sex steroid receptors in the ovaries, oviducts, and uteri of adult rats. Reprod Toxicol 39: 40-49.
35. Wang Y, Millonig G, Nair J, Patsenker E, Stickel F, et al. (2009) Ethanol-induced cytochrome P-4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50: 453-461.
36. Poschl G, Seitz HK (2004) Alcohol and cancer. Alcohol Alcohol 39: 155-165. (Pubitemid 38578731)
37. King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, et al. (2011) The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 18, 627-642.
38. Crespi F (2012) Influence of melatonin or its antagonism on alcohol consumption in ethanol drinking rats: a behavioral and in vivo voltammetric study. Brain Res 1452: 39-46.
39. Srinivasan V, Pandi-Perumal SR, Brzezinski A, Bhatnagar KP, Cardinali DP (2011) Melatonin, immune function and cancer. Recent Pat Endocr Metab Immune Drug Discov 5: 109-123.
40. Lissoni P (2007) Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. Pathol Biol 55: 201-204.
41. Molpeceres V, Mauriz JL, Garcia-Mediavilla MV, Gonzalez P, Barrio JP, et al. (2007) Melatonin is able to reduce the apoptotic liver changes induced by aging via inhibition of the intrinsic pathway of apoptosis. J Gerontol A Biol Sci Med Sci 62: 687-695. (Pubitemid 350143598)
42. Xi SC, Siu SW, Fong SW, Fong SW, Shiu SY (2001) Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression. Prostate 46: 52-61. (Pubitemid 32157776)
43. Prata Lima MF, Baracat EC, Simões MJ (2004) Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res 37: 987-995. (Pubitemid 39029118)
44. Chuffa LG, Amorim JP, Teixeira GR, Mendes LO, Fioruci BA, et al. (2011c) Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat. Braz J Med Biol Res 44: 217-223.
45. Godwin AK, Testa JR, Handel LM, Liu Z, Vanderveer LA, et al. (1992) Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 84: 592-601.
46. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, et al. (2007) Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem 102: 1117-1129. (Pubitemid 350220033)
47. Huang Y, Jiang W, Wang Y, Zheng Y, Cong Q, et al. (2012) Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat. J Ovarian Res 5: 21.
48. Crist KA, Zhang Z, You M, Gunning WT, Conran PB, et al. (2005) Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 26: 951-957. (Pubitemid 41214324)
49. Stewart SL, Querec TD, Ochman AR, Gruver BN, Bao R, et al. (2004) Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res 64, 8177-8183. (Pubitemid 39491753)
50. Vanderhyden BC, Shaw TJ, Ethier JF (2003) Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67.
51. Peres R, do Amaral FG, Madrigrano TC, Scialfa JH, Bordin S, et al. (2011) Ethanol consumption and pineal melatonin daily profile in rats. Addict Biol 16: 580-590.
52. Fisher SP, Sugden D (2010) Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle. Sleep 33, 833-840.
53. Treeck O, Haldar C, Ortmann O (2006) Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol rep 15: 231-235.